

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tis⦠read more
Healthcare
Medical Instruments & Supplies
24 years
USD
Exclusive to Premium users
$0.65
Price-2.78%
-$0.02
$28.970m
Small
-
Premium
Premium
+5.6%
EBITDA Margin-6.0%
Net Profit Margin+3.0%
Free Cash Flow Margin+5.6%
EBITDA Margin-6.0%
Net Profit Margin+3.0%
Free Cash Flow Margin$87.371m
-7.2%
1y CAGR-8.1%
3y CAGR-7.2%
5y CAGR-$53.835m
-334.0%
1y CAGR-177.7%
3y CAGR-934.3%
5y CAGR-$1.22
-335.7%
1y CAGR-173.5%
3y CAGR-680.1%
5y CAGR$14.068m
$77.992m
Assets$63.924m
Liabilities$42.785m
Debt54.9%
-1x
Debt to EBITDA$6.877m
+477.2%
1y CAGR+1045.6%
3y CAGR+677.3%
5y CAGR